Soleno Therapeutics, Inc. (SLNO)
53.01
0.00 (0.00%)
USD |
NASDAQ |
May 18, 16:00
Soleno Therapeutics EPS Diluted (TTM) : 1.762 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | 6.504 |
| Nektar Therapeutics | -8.420 |
| XOMA Royalty Corp. | 1.571 |
| Apellis Pharmaceuticals, Inc. | 1.001 |
| Forian, Inc. | -0.1643 |